Key result
Changes in systolic blood pressure variation correlated with changes in arterial rigidity and inflammation in hypertensive patients over 1 year.
Why the study?
Does blood pressure control treatment improve systolic blood pressure variation, arterial rigidity, and inflammation in patients with essential hypertension?
Observational (n=98)
Does blood pressure control treatment improve systolic blood pressure variation, arterial rigidity, and inflammation in patients with essential hypertension?
Answers are grounded in this paper and cite their sources.
Reductions in systolic blood pressure variability correlate with improvements in arterial stiffness and inflammation, suggesting that controlling blood pressure variation may mitigate vascular damage.
Objective: To assess the relationship among systolic blood pressure variation (BPV), inflammation and arterial rigidity in essential hypertension. Methods: This study enrolled 80 patients with essential hypertension, who were started on blood pressure control treatment with medications and lifestyle modification, and 18 normotensive healthy controls. At enrollment and 1-year follow-up, systolic BPV was evaluated by coefficient of variation (CV) in ambulatory blood pressure monitoring; arterial rigidity by brachial-ankle pulse wave velocity (ba-PWV) using ColinVP-1000; and inflammation by high-sensitivity plasma C-reactive protein (hs-CRP) level using rate nephelometry; electrocardiography, blood glucose, lipid profile, creatinine, blood urea nitrogen, and liver and renal function also were assessed. Results: There were no significant differences in demographics, clinical or biochemical profiles between patients and normotensive controls, except for blood pressure at enrollment but not 1-year follow-up, reflecting effectiveness of blood pressure control measures, with significant decreases in CV, ba-PWV and hs-CRP between enrollment and 1-year follow-up in hypertensive patients; change in CV significantly correlated with those in ba-PWV and hs-CRP (both P<0.001, adjusted by SBP d). Conclusion: The effect of systolic BPV on arterial rigidity could be mediated by its influence on the onset and progression of inflammation.
No takes yet. Share an insight, caveat, or question.
Jiangyan et al. (2015) conducted an observational in Essential hypertension (n=98). Systolic blood pressure variation (BPV) vs. Normotensive healthy controls was evaluated on Correlation between change in systolic BPV (CV) and changes in arterial rigidity (ba-PWV) and inflammation (hs-CRP) (p=<0.001). Changes in systolic blood pressure variation correlated with changes in arterial rigidity and inflammation in hypertensive patients over 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: